Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Skip to Content

Video: BRUKINSA® (Zanubrutinib) for Treatment of Waldenstrom’s Macroglobulinemia

Published Date: April 16, 2025

This NCODA educational video explores the evolving landscape of oral oncolytics and the vital role pharmacy professionals play in ensuring safe, effective treatment. As oral chemotherapy becomes more prevalent, the responsibility of pharmacists in supporting patients through education, adherence, and access continues to grow. This video provides practical strategies and real-world insights to empower pharmacy teams in delivering value-based, patient-centered oncology care.

Topics covered include:

  • Key considerations in the handling and dispensing of oral oncolytics
  • The impact of oral therapies on patient experience and outcomes
  • Approaches for improving adherence and reducing barriers to care
  • The pharmacist’s role in monitoring side effects and treatment success
  • Tools and practices that support coordinated, high-quality cancer care

 

View Prescribing Information

Sponsored by